Try the Demo today!
| SEC Filing | Company/Stock | Trade Date | Transaction | Shares | Avg. Price | Total | % Holdings | Gain/Loss |
|---|---|---|---|---|---|---|---|---|
| 15-Mar-24 7:23 PM View:  | Kymera Therapeutics, Inc. (KYMR) | 15-Mar-24 | Sale (Planned) | 71,764 | $40.46 | $2,903,340.00 | (1%) 5.45M to 5.38M | |
| 15-Mar-24 7:23 PM View: | Kymera Therapeutics, Inc. (KYMR) | 14-Mar-24 | Sale (Planned) | 55,779 | $39.98 | $2,229,930.00 | (1%) 5.5M to 5.45M | |
| 13-Mar-24 7:52 PM View: | Kymera Therapeutics, Inc. (KYMR) | 13-Mar-24 | Sale (Planned) | 139,255 | $42.23 | $5,880,420.00 | (2%) 5.64M to 5.5M | |
| 13-Mar-24 7:52 PM View: | Kymera Therapeutics, Inc. (KYMR) | 12-Mar-24 | Sale (Planned) | 162,918 | $41.98 | $6,838,810.00 | (3%) 5.81M to 5.64M | |
| 13-Mar-24 7:52 PM View: | Kymera Therapeutics, Inc. (KYMR) | 11-Mar-24 | Sale (Planned) | 51,184 | $42.85 | $2,193,150.00 | (< 1%) 5.86M to 5.81M | |
| 13-Jan-23 4:53 PM View: | Kymera Therapeutics, Inc. (KYMR) | 12-Jan-23 | Sale (Planned) | 98,720 | $30.29 | $2,990,230.00 | (2%) 5.96M to 5.86M | |
| 13-Jan-23 4:53 PM View: | Kymera Therapeutics, Inc. (KYMR) | 11-Jan-23 | Sale (Planned) | 27,754 | $29.96 | $831,510.00 | (< 1%) 5.98M to 5.96M | |
| 16-Dec-22 5:05 PM View: | Kymera Therapeutics, Inc. (KYMR) | 15-Dec-22 | Sale (Planned) | 3,278 | $30.00 | $98,340.00 | (< 1%) 5.99M to 5.98M | |
| 16-Dec-22 5:05 PM View: | Kymera Therapeutics, Inc. (KYMR) | 14-Dec-22 | Sale (Planned) | 378,966 | $31.37 | $11,887,600.00 | (6%) 6.37M to 5.99M | |
| 04-Nov-22 4:31 PM View: | Kymera Therapeutics, Inc. (KYMR) | 03-Nov-22 | Sale (Planned) | 96,397 | $30.00 | $2,891,910.00 | (1%) 6.46M to 6.37M | |
| 04-Nov-22 4:31 PM View: | Kymera Therapeutics, Inc. (KYMR) | 02-Nov-22 | Sale (Planned) | 123,619 | $30.02 | $3,711,040.00 | (2%) 6.59M to 6.46M | |
| 01-Nov-22 7:36 PM View: | Kymera Therapeutics, Inc. (KYMR) | 01-Nov-22 | Sale (Planned) | 77,030 | $30.60 | $2,357,240.00 | (1%) 6.66M to 6.59M | |
| 01-Nov-22 7:36 PM View: | Kymera Therapeutics, Inc. (KYMR) | 31-Oct-22 | Sale (Planned) | 120,622 | $30.23 | $3,646,400.00 | (2%) 6.78M to 6.66M | |
| 01-Nov-22 7:36 PM View: | Kymera Therapeutics, Inc. (KYMR) | 28-Oct-22 | Sale (Planned) | 91,050 | $30.00 | $2,731,500.00 | (1%) 6.88M to 6.78M | |
| 11-Jan-22 9:11 PM View: | Vigil Neuroscience, Inc. (VIGL) | 11-Jan-22 | Conversion Duplicate | 3,859,500 | -- | -- | 268% 1.44M to 5.3M | |
| 11-Jan-22 9:11 PM View: | Vigil Neuroscience, Inc. (VIGL) | 11-Jan-22 | Purchase | 535,000 | $14.00 | $7,490,000.00 | 10% 5.3M to 5.84M | |
| 12-Aug-21 10:43 AM View: | Kymera Therapeutics, Inc. (KYMR) | 11-Aug-21 | Market Sale Duplicate | 242,133 | $61.00 | $14,770,100.00 | (3%) 7.12M to 6.88M | 7% |
| 16-Mar-21 7:39 PM View: | Kymera Therapeutics, Inc. (KYMR) | 12-Mar-21 | Market Sale Duplicate | 229,350 | $56.50 | $12,958,300.00 | (3%) 8.23M to 8.0M | (6%) |
| 25-Aug-20 4:30 PM View: | Kymera Therapeutics, Inc. (KYMR) | 25-Aug-20 | Conversion | 8,309,270 | -- | -- | 1104% 752.4K to 9.06M | |
| 01-Jul-20 4:48 PM View: | Dianthus Therapeutics, Inc.... (DNTH) | 29-Jun-20 | Market Purchase | 1,250,000 | $8.00 | $10,000,000.00 | 30% 4.12M to 5.37M | (4%) |
| 23-Jul-19 4:09 PM View: | Avrobio, Inc. (AVRO) | 19-Jul-19 | Private Purchase | 810,811 | $18.50 | $15,000,000.00 | 17% 4.76M to 5.57M | |
| 22-Mar-19 5:01 PM View: | Dianthus Therapeutics, Inc.... (DNTH) | 20-Mar-19 | Acquisition (other) | 14,245 | -- | -- | < 1% 4.84M to 4.86M | |
| 22-Mar-19 5:01 PM View: | Dianthus Therapeutics, Inc.... (DNTH) | 20-Mar-19 | Disposition (other) Duplicate | 726,500 | -- | -- | (15%) 4.86M to 4.13M | |
| 22-Mar-19 5:01 PM View: | Dianthus Therapeutics, Inc.... (DNTH) | 20-Mar-19 | Market Sale | 14,245 | $17.86 | $254,416.00 | (< 1%) 4.13M to 4.12M | 57% |
| 25-Jun-18 6:15 PM View: | Avrobio, Inc. (AVRO) | 25-Jun-18 | Conversion | 4,756,480 | -- | -- | 100% 0 to 4.76M | |
| 27-Jun-18 4:28 PM View: | Dianthus Therapeutics, Inc.... (DNTH) | 25-Jun-18 | Conversion Duplicate | 4,746,880 | -- | -- | 4906% 96.74K to 4.84M | |
| 03-Apr-18 5:07 PM View: | Cogent Biosciences, Inc. (COGT) | 03-Apr-18 | Conversion Duplicate | 3,267,480 | -- | -- | 100% 0 to 3.27M | |
| 03-Apr-18 5:07 PM View: | Cogent Biosciences, Inc. (COGT) | 03-Apr-18 | Purchase Duplicate | 94,052 | $12.00 | $1,128,620.00 | 3% 3.27M to 3.36M | |
| 13-Feb-18 4:59 PM View: | Viridian Therapeutics, Inc.... (VRDN) | 13-Feb-18 | Market Purchase | 545,454 | $5.50 | $3,000,000.00 | 14% 3.95M to 4.49M | (69%) |
| 27-Jan-16 9:18 PM View: | Larimar Therapeutics, Inc. (LRMR) | 25-Jan-16 | Grant | 4,424 | $7.91 | $34,993.80 | < 1% 4.63M to 4.64M | 55% |
| 12-Jan-15 7:41 PM View: | Larimar Therapeutics, Inc. (LRMR) | 08-Jan-15 | Grant | 874 | $40.04 | $34,995.00 | < 1% 5.63M to 5.63M | (69%) |
| 26-Jun-14 4:18 PM View: | Larimar Therapeutics, Inc. (LRMR) | 24-Jun-14 | Conversion Duplicate | 5,632,730 | -- | -- | 100% 0 to 5.63M |